Achilles Therapeutics PLC - ADR

NAS:ACHL (UK)   ADR
$ 0.80 -0.0204 (-2.48%) 10:08 PM EST
At Loss
P/B:
0.23
Market Cap:
$ 33.29M
Enterprise V:
$ -92.79M
Volume:
129.97K
Avg Vol (2M):
873.78K
Also Trade In:
Volume:
129.97K
At Loss
Avg Vol (2M):
873.78K

Business Description

Achilles Therapeutics PLC

ISIN : US00449L1026

Share Class Description:

ACHL: ADR
Description
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
Name Current Vs Industry Vs History
Cash-To-Debt 28.5
Equity-to-Asset 0.88
Debt-to-Equity 0.03
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 19.2
9-Day RSI 23.66
14-Day RSI 30.09
6-1 Month Momentum % 23.6
12-1 Month Momentum % 23.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.57
Quick Ratio 8.57
Cash Ratio 7.74

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.4
Shareholder Yield % 8.33

Financials (Next Earnings Date:2024-05-10 Est.)

ACHL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ACHL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Achilles Therapeutics PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.74
Beta 1.09
Volatility % 52.88
14-Day RSI 30.09
14-Day ATR ($) 0.08891
20-Day SMA ($) 1.07908
12-1 Month Momentum % 23.6
52-Week Range ($) 0.7402 - 1.76
Shares Outstanding (Mil) 39.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Achilles Therapeutics PLC Filings

Filing Date Document Date Form
No Filing Data

Achilles Therapeutics PLC Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Achilles Therapeutics PLC Frequently Asked Questions

What is Achilles Therapeutics PLC(ACHL)'s stock price today?
The current price of ACHL is $0.80. The 52 week high of ACHL is $1.76 and 52 week low is $0.74.
When is next earnings date of Achilles Therapeutics PLC(ACHL)?
The next earnings date of Achilles Therapeutics PLC(ACHL) is 2024-05-10 Est..
Does Achilles Therapeutics PLC(ACHL) pay dividends? If so, how much?
Achilles Therapeutics PLC(ACHL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1